## Background: [f-18]fluorodeoxyglucose (fdg)-positron emission tomography (pet) can measure the metabolic activity of tissues; fdg-pet may be able to predict response to chemotherapy by identifying changes in tumor metabolism. measurement of response to treatment may help improve survival in the m
[18F]-Fluorodeoxyglucose-positron emission tomography findings in preterm infants with severe periventricular leukomalacia and hypsarrhythmia
β Scribed by Y. Higuchi; T. Maihara; H. Hattori; K. Furusho; H. Okazawa; K. Ishizu; Y. Yonekura
- Publisher
- Springer
- Year
- 1997
- Tongue
- English
- Weight
- 949 KB
- Volume
- 156
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Background. Conventional imaging is limited in identifying persistent disease after organβpreserving therapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). We studied the accuracy of positron emission tomography (PET) with ^18^Fβfluoroβ2βdeoxyβDβglu
## Abstract ## Background The aim of our study was to assess the value of positron emission tomography (PET) with 18Fβfluorodeoxyglucose (FDG) for the staging of clinically nodal negative necks in oral and oropharyngeal squamous cell carcinoma (SCC) using sentinel lymph node (SLN) biopsy and elect